The shortage of available donor hearts continues to limit cardiac transplantation. For this
reason, strict criteria have limited the number of patients placed on the US waiting list to≈ …

Aims We sought to determine the influence of genotype on clinical course and arrhythmic
outcome among arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) …

Among the estimated 6.2 million Americans living with heart failure (HF),≈ 5%/y may
progress to advanced, or stage D, disease. Advanced HF has a high morbidity and mortality …

Background Patients with advanced heart failure have improved survival rates and quality of
life when treated with implanted pulsatile-flow left ventricular assist devices as compared …

Background The use of left ventricular assist devices is an accepted therapy for patients with
refractory heart failure, but current pulsatile volume-displacement devices have limitations …

Summary Background Cardiosphere-derived cells (CDCs) reduce scarring after myocardial
infarction, increase viable myocardium, and boost cardiac function in preclinical models. We …

CO-CHAIRS: Feldman D: Minneapolis Heart Institute, Minneapolis, Minnesota, Georgia
Institute of Technology and Morehouse School of Medicine; Pamboukian SV: University of …

Objectives: This study sought to evaluate the use of a continuous-flow rotary left ventricular
assist device (LVAD) as a bridge to heart transplantation. Background: LVAD therapy is an …

Continuous-flow left ventricular assist devices (LVAD) have emerged as the standard of care
for advanced heart failure patients requiring long-term mechanical circulatory support …

OBJECTIVE: The aim of this study was to evaluate the incidence, risk factors, and effect on
outcomes of right ventricular failure in a large population of patients implanted with …